Monique D Courtenay1, William Cade2, Stephen G Schwartz3, Jaclyn L Kovach4, Anita Agarwal5, Gaofeng Wang6, Jonathan L Haines7, Margaret A Pericak-Vance8, Wiliam K Scott9. 1. Human Genetics and Genomics, University of Miami Miller School Medicine, 1501 NW 10th Ave, Miami, FL, 33136, United States. 2. John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, 1501 NW 10 Ave, BRB-314 (M860), Miami, Florida, 33136, United States. 3. Ophthalmology, Bascom Palmer Eye Institute, Retina Center of Naples, 311 9th Street North, Naples, Florida, 34102, United States of America. 4. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9th St N, Naples, FL, 34102, United States of America. 5. VEI, Vanderbilt University, 2311 Pierce avenue, Nashville, Tennessee, 37232-8808, United States of America. 6. Human Genetics, University of Miami Miller School of Medicine, 1501 NW 10th Avenue; BRB 525, Miami, Florida, 33136, United States. 7. Department of Epidemiology & Biostatistics, Case Western Reserve University, 2-529 Wolstein Research Building, 2103 Cornell Road, Cleveland, Ohio, 44106, United States. 8. John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, 1501 NW 10th Avenue, BRB-314 (M860), Miami, Florida, 33136, United States of America. 9. Dr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, 1501 NW 10 Ave., Biomedical Research Building (BRB) # 414, Miami, Florida, 33136, United States w.scott@med.miami.edu.
Abstract
Purpose:Age-Related Macular Degeneration (AMD) is the leading cause of irreversible visual loss in developed countries. Its etiology includes genetic and environmental factors. Although VEGFA variants are associated with AMD, the joint action of variants within the VEGF pathway and their interaction with non-genetic factors has not been investigated. Methods: Affymetrix 6.0 chipsets were used to genotype 668,238 SNPs in 1,207 AMD cases and 686 controls. Environmental exposures were collected by questionnaire. A set-based test was conducted using the chi-square statistic at each SNP derived from Kraft's 2df joint test. Pathway and gene-based test statistics were calculated as the mean of all independent SNP statistics. Phenotype labels were permuted 10,000 times to generate an empirical p-value. Results: While a main effect of the VEGF pathway was not identified, the pathway was associated with neovascular AMD in women when accounting for birth control pill (BCP) use (P= 0.017). Analysis of VEGF's subpathways found that SNPs in the Proliferation subpathway were associated with neovascular AMD (P=0.029) when accounting for BCP use. Nominally significant genes within this subpathway were also observed. Stratification by BCP use revealed novel significant genetic effects in women who had taken BCPs. Conclusions: These results illustrate that some AMD genetic risk factors may only be revealed when considering complex relationships among risk factors. This shows the utility of exploring pathways of previously associated genes to find novel effects. It also demonstrates the importance of incorporating environmental exposures in tests of genetic association at the SNP, gene, or pathway level.
Purpose:Age-Related Macular Degeneration (AMD) is the leading cause of irreversible visual loss in developed countries. Its etiology includes genetic and environmental factors. Although VEGFA variants are associated with AMD, the joint action of variants within the VEGF pathway and their interaction with non-genetic factors has not been investigated. Methods: Affymetrix 6.0 chipsets were used to genotype 668,238 SNPs in 1,207 AMD cases and 686 controls. Environmental exposures were collected by questionnaire. A set-based test was conducted using the chi-square statistic at each SNP derived from Kraft's 2df joint test. Pathway and gene-based test statistics were calculated as the mean of all independent SNP statistics. Phenotype labels were permuted 10,000 times to generate an empirical p-value. Results: While a main effect of the VEGF pathway was not identified, the pathway was associated with neovascular AMD in women when accounting for birth control pill (BCP) use (P= 0.017). Analysis of VEGF's subpathways found that SNPs in the Proliferation subpathway were associated with neovascular AMD (P=0.029) when accounting for BCP use. Nominally significant genes within this subpathway were also observed. Stratification by BCP use revealed novel significant genetic effects in women who had taken BCPs. Conclusions: These results illustrate that some AMD genetic risk factors may only be revealed when considering complex relationships among risk factors. This shows the utility of exploring pathways of previously associated genes to find novel effects. It also demonstrates the importance of incorporating environmental exposures in tests of genetic association at the SNP, gene, or pathway level.
Authors: Silke Schmidt; Michael A Hauser; William K Scott; Eric A Postel; Anita Agarwal; Paul Gallins; Frank Wong; Yu Sarah Chen; Kylee Spencer; Nathalie Schnetz-Boutaud; Jonathan L Haines; Margaret A Pericak-Vance Journal: Am J Hum Genet Date: 2006-03-20 Impact factor: 11.025
Authors: Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance Journal: Science Date: 2005-03-10 Impact factor: 47.728
Authors: Bruce F Bebo; Babak Dehghani; Scott Foster; Astrid Kurniawan; Francisco J Lopez; Larry S Sherman Journal: Glia Date: 2009-05 Impact factor: 7.452
Authors: Yi Yu; Tushar R Bhangale; Jesen Fagerness; Stephan Ripke; Gudmar Thorleifsson; Perciliz L Tan; Eric H Souied; Andrea J Richardson; Joanna E Merriam; Gabriëlle H S Buitendijk; Robyn Reynolds; Soumya Raychaudhuri; Kimberly A Chin; Lucia Sobrin; Evangelos Evangelou; Phil H Lee; Aaron Y Lee; Nicolas Leveziel; Donald J Zack; Betsy Campochiaro; Peter Campochiaro; R Theodore Smith; Gaetano R Barile; Robyn H Guymer; Ruth Hogg; Usha Chakravarthy; Luba D Robman; Omar Gustafsson; Haraldur Sigurdsson; Ward Ortmann; Timothy W Behrens; Kari Stefansson; André G Uitterlinden; Cornelia M van Duijn; Johannes R Vingerling; Caroline C W Klaver; Rando Allikmets; Milam A Brantley; Paul N Baird; Nicholas Katsanis; Unnur Thorsteinsdottir; John P A Ioannidis; Mark J Daly; Robert R Graham; Johanna M Seddon Journal: Hum Mol Genet Date: 2011-06-10 Impact factor: 6.150
Authors: Jihye Kim; Andrey Ziyatdinov; Vincent Laville; Frank B Hu; Eric Rimm; Peter Kraft; Hugues Aschard Journal: Genetics Date: 2018-12-21 Impact factor: 4.562
Authors: Joseph M Simonett; Mahsa A Sohrab; Jennifer Pacheco; Loren L Armstrong; Margarita Rzhetskaya; Maureen Smith; M Geoffrey Hayes; Amani A Fawzi Journal: Sci Rep Date: 2015-08-10 Impact factor: 4.379
Authors: Andrea R Waksmunski; Michelle Grunin; Tyler G Kinzy; Robert P Igo; Jonathan L Haines; Jessica N Cooke Bailey Journal: Invest Ophthalmol Vis Sci Date: 2019-09-03 Impact factor: 4.799